Accuri and eBIOSCIENCE Partner to Offer Complete Flow Cytometry Solutions
News May 11, 2010
Accuri Cytometers, Inc. and eBioscience announced that they have entered into a worldwide co-marketing agreement.
The collaboration is designed to offer scientists a better and more comprehensive solution for their flow cytometry research needs, harnessing ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with extensive line of high quality cytometer research reagents offered by eBioscience.
Explicitly designed for routine use by biomedical researchers in their own labs, Accuri’s full-featured bench-top cell analysis system provides capabilities similar to flow cytometers in a user-friendly format and at a fraction of the cost. eBioscience, which is among the largest suppliers of flow cytometry research reagents worldwide, offers a wide range of high quality flow cytometry research reagents optimized for a variety of applications.
Accuri designed the C6 system from the ground up with input from hundreds of researchers. Accuri's innovations, coupled with its components, resulted in a cytometer that is robust, compact, easy-to-use and affordable, at less than one-third the price of current flow cytometers and one-tenth the operating costs of the market leaders over five years of ownership, the companies say.
Further terms of the agreement were not disclosed.
Stem Cell Signaling Drives Mammary Gland DevelopmentNews
New research illuminates the biology of breast tissue development and may pave the way to new strategies for diagnosing or even treating cancer.READ MORE
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018